Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
Anne Lautenbach, Marie Wernecke, Tobias B. Huber, et al.
Obesity Surgery (2022) Vol. 32, Iss. 10, pp. 3280-3288
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Anders Boisen Jensen, Frida Renström, Stefan Aczél, et al.
Obesity Surgery (2023) Vol. 33, Iss. 4, pp. 1017-1025
Open Access | Times Cited: 89
Randomized Trial of Effect of Bariatric Surgery on Blood Pressure After 5 Years
Carlos A. Schiavon, Alexandre Biasi Cavalcanti, Juliana D. Oliveira, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 6, pp. 637-648
Closed Access | Times Cited: 27
Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels
Nursel Çalık Başaran, I Dotan, Dror Dicker
International Journal of Obesity (2024)
Open Access | Times Cited: 20
Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition
Fabian Stoll, Tobias Kantowski, Jonas Laaser, et al.
Obesity Research & Clinical Practice (2025) Vol. 19, Iss. 1, pp. 63-69
Open Access | Times Cited: 3
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 2
Pediatric Obesity: Complications and Current Day Management
Mary Ellen Vajravelu, Emir Tas, Silva Arslanian
Life (2023) Vol. 13, Iss. 7, pp. 1591-1591
Open Access | Times Cited: 31
Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study
Mohammad H. Jamal, Mohsen Alhashemi, Carol Dsouza, et al.
Obesity Surgery (2024) Vol. 34, Iss. 4, pp. 1324-1332
Closed Access | Times Cited: 15
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis
Deep Dutta, Lakshmi Nagendra, Ameya Joshi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1653-1664
Closed Access | Times Cited: 13
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis
Yuntao Nie, Yiran Zhang, Baoyin Liu, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery
J. Ferguson, Oliver M. Fisher, Michael Talbot, et al.
Obesity Surgery (2025)
Open Access | Times Cited: 1
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review
Alexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1846-1854
Closed Access | Times Cited: 8
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
Caroline K. Kramer, Matthew Retnakaran, Luciana Verçoza Viana
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. e1634-e1641
Closed Access | Times Cited: 8
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement
Ashraf Haddad, Michel Suter, Jan Greve, et al.
Obesity Surgery (2024) Vol. 34, Iss. 11, pp. 3944-3962
Closed Access | Times Cited: 7
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
Jean‐Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Obesity (2023) Vol. 32, Iss. 1, pp. 50-58
Open Access | Times Cited: 15
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity
L Horvath, Miloš Mráz, Edward B. Jude, et al.
Drugs (2024) Vol. 84, Iss. 8, pp. 933-952
Open Access | Times Cited: 5
Glucagon-like peptide-1 receptor agonists for post-bariatric surgery weight regain and insufficient weight loss: A systematic review
Kevin Gracia Pratama, Heri Nugroho, Antoninus Hengky, et al.
Obesity Medicine (2024) Vol. 46, pp. 100533-100533
Closed Access | Times Cited: 4
Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review
Theo Sher, Michelle Y. McGee, Christopher DuCoin, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 2, pp. 377-402
Closed Access | Times Cited: 4
Semaglutide for weight loss: unanswered questions
Ploutarchos Tzoulis, Stephanie Baldeweg
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis
Ali Esparham, Ali Mehri, Amin Dalili, et al.
Obesity Reviews (2024) Vol. 25, Iss. 11
Open Access | Times Cited: 4
A Randomized, Double-Blind, Two-Way Cross-over Study to Evaluate the Efficacy of Liraglutide Treatment in Patients Undergoing Transoral Outlet Reduction Endoscopy for Weight Regain Post Roux-en-Y Gastric Bypass
Ali Lahooti, Anna Carolina Hoff, Brian Critelli, et al.
Obesity Surgery (2025)
Closed Access
Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery
J Cunningham, Nova Szoka, Lawrence Tabone, et al.
Surgery for Obesity and Related Diseases (2023) Vol. 19, Iss. 8, pp. 832-840
Closed Access | Times Cited: 10
Practical guide: Glucagon-like peptide-1 and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus
Saleh Fahad Alqifari, Omar Al Komi, Abdullah Esmail, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 331-347
Open Access | Times Cited: 3
Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review
Ricardo V. Cohen, Ji Yeon Park, Gerhard Prager, et al.
British journal of surgery (2024) Vol. 111, Iss. 12
Open Access | Times Cited: 3
Weight Regain after Bariatric and Metabolic Surgery: A Dreaded Complication
Ihsan Ullah, Muhammad Jamil, Johar Jamil
IntechOpen eBooks (2025)
Closed Access
Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy
Firas Bahdi, Sagar Shah, Fadi Dahoud, et al.
Clinical Obesity (2025)
Closed Access
Page 1 - Next Page

Scroll to top